Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 310,460 | reported | 31 Dec 2025 | tx 545+12,999,702−12,052,985 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 28,570 | 0.00 USD | |
| 31 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 28,570 | 772.09 USD | |
| 31 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 28,570 | 0.00 USD | deriv |
| 09 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 146,815 | 555.67 USD | |
| 09 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 131,874 | 701.51 USD | |
| 09 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 146,815 | 0.00 USD | deriv |
| 10 Jun 2024 | GIFT | REGENERON PHARMACEUTICALS, INC. | 37,900 | 0.00 USD | |
| 10 Jun 2024 | GIFT | REGENERON PHARMACEUTICALS, INC. | 75,799 | 0.00 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 3,387 | 968.43 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 373 | 988.36 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 182 | 987.38 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 442 | 986.40 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 647 | 985.62 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 53 | 984.02 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 727 | 983.88 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 303 | 982.29 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,283 | 981.52 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,223 | 980.72 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 504 | 979.87 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 4,865 | 978.44 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 9,851 | 977.42 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 6,885 | 976.56 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 111 | 965.69 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 782 | 966.29 USD | |
| 15 May 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,428 | 967.45 USD |